Cancer Research Cancer Epigenetics  Sign up for Cancer Research eTOC's
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 42, 2250-2254, June 1, 1982]
© 1982 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tsuruo, T.
Right arrow Articles by Sakurai, Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tsuruo, T.
Right arrow Articles by Sakurai, Y.

Enzyme Catalyzation of the Deacylation of N4-Acyl Derivatives of 1-ß-D-Arabinofuranosylcytosine in the Mouse Liver Microsome1

Takashi Tsuruo2, Kazuyoshi Hori3, Harumi Iida, Shigeru Tsukagoshi and Yoshio Sakurai

Cancer Chemotherapy Center, Japanese Foundation for Cancer Research, Toshima-ku, Tokyo 170, Japan

Enzymatic hydrolysis of acylamide of N4-acyl-1-ß-D-arabinofuranosylcytosine was studied. The highest enzyme activity among various homogenates from mouse tissues, as expressed by specific activity, was found in liver homogenate. More than 50% of the activity in the liver was found in the microsomal fraction. The hydrolysis products of N4-palmitoyl-1-ß-D-arabinofuranosylcytosine by microsomal enzyme were identified stoichiometrically as 1-ß-D-arabinofuranosylcytosine and palmitic acid. The microsomal enzyme showed an optimum pH at 9.0 in Tris-HCI buffer. Michaelis constant for N4-palmitoyl-1-ß-D-arabinofuranosylcytosine was 2.5 x 10-5 M. The enzyme did not require divalent cations for the reaction. Mn2+ and Co2+ at 1 mM strongly inhibited the reaction. The relative rates of hydrolysis of N4-palmitoyl-, N4-stearoyl-, N4-lauroyl-, N4-butyryl-, and N4-behenoyl-1-ß-D-arabinofuranosylcytosine were 100, 47.6, 31.3, 15.9, and 9.1, respectively. The enzyme might play an important role in the formation of 1-ß-D-arabinofuranosylcytosine from N4-acyl derivatives of 1-ß-D-arabinofuranosylcytosine.

1 This work was supported by Grant-in-Aids for Cancer Research from the Ministry of Education, Science, and Culture and the Ministry of Health and Welfare, Japan.

2 To whom requests for reprints should be addressed.

3 Research Fellow from Asahi Chemical Industry, Ltd., Nobeoka, Japan.

Received 9/ 8/81. Accepted 3/12/82.




This article has been cited by other articles:


Home page
Drug Metab. Dispos.Home page
S. K. M. Koller-Lucae, M. J.-F. Suter, K. M. Rentsch, H. Schott, and R. A. Schwendener
Metabolism of the New Liposomal Anticancer Drug N4-Octadecyl-1-beta -D-Arabinofuranosylcytosine in Mice
Drug Metab. Dispos., March 1, 1999; 27(3): 342 - 350.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1982 by the American Association for Cancer Research.